Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alvotech Swiss AG
Age
50–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject must be ≥50 years of age, at the time of signing the informed consent.
Subjects must be diagnosed with neovascular (wet) AMD in the study eye.
Subjects must have active, treatment naïve, subfoveal CNV lesions secondary to neovascular (wet) AMD.
Willingness and ability to undertake all scheduled visits and assessments.
You may not be if
Any prior systemic treatment with anti-VEGF therapy
Any condition that, in the Investigator ́s opinion, can interfere with full participation in the study, including administration of the study treatment and attending required visits; can pose a significant risk to the participant, or interfere with interpretation of study data
Prior treatment with any investigational drugs within 30 days or 5 half-lives (whichever is longer) of the previous investigational treatment before initiation of the study treatment or concomitant enrollment in any other clinical study involving an investigational study treatment
Subjects not suitable for participation, whatever the reason, as judged by the Investigator, including medical or psychiatric conditions, or participants potentially at risk of noncompliance to study procedures.